Indian Ezetimibe Exporters: Complete Supplier Ranking with Market Share — 466 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ezetimibe buyer importing from India?

DAIICHI SANKYO EUROPE GMBH (GERMANY) is the largest ezetimibe importer from India with a 38.9% market share and import value of $200.3M.

Q: How many ezetimibe buyers import from India?

There are 466 active ezetimibe buyers importing from India, with a combined import market of $514.5M across 5,033 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ezetimibe buyers from India?

The top 5 ezetimibe buyers — DAIICHI SANKYO EUROPE GMBH, PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, BGP PRODUCTS GMBH, NEXTPHARMA LOGISTIC GMBH — together control 84.1% of total ezetimibe import value from India.

Suresh Sormare

Ezetimibe

India Pharmaceutical Trade Intelligence

$514.5M169 Suppliers85 CountriesHS 30049099

ExportsIndia → UNITED STATES44.9%India → GERMANY41.4%

ImportsMALTA → India$3.0M GERMANY → India$37.8K

#1 Supplier: PIRAMAL PHARMA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $231.1M through 313 shipments. This represents a market share of 44.9% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• PCI PHARMA SERVICES - $109.0M (47.2% of country's total business)

• ASCEND LABORATORIES LLC - $99.8M (43.2% of country's total business)

• ASCEND LABORATORIES,LLC - $6.7M (2.9% of country's total business)

• SENTRY BIOPHARMA SERVICES, INC - $3.4M (1.5% of country's total business)

• ESPERION THERAPEUTICS INC. - $1.6M (0.7% of country's total business)

• Rest of United States's importers - $10.6M (4.6% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $738.4K, indicating premium pricing strategy compared to the market average of $102.2K.

United States is a key market for Ezetimibe imports, representing 44.9% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Ezetimibe buyer market intelligence

1Buyer Segment Analysis

Ezetimibe imports from India are primarily distributed among the following buyer segments:

1. Pharmaceutical Companies and Contract Manufacturers: These entities procure Ezetimibe as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Notable buyers in this category include DAIICHI SANKYO EUROPE GMBH (Germany, $200.28M) and BGP PRODUCTS GMBH (Netherlands, $16.35M). Their purchasing behavior is characterized by large-volume orders to meet production demands, often engaging in long-term supply agreements to ensure consistent API availability.

2. Distributors and Logistics Providers: Companies such as PCI PHARMA SERVICES (United States, $109.00M) and NEXTPHARMA LOGISTIC GMBH (Germany, $7.21M) fall into this segment. They specialize in the distribution and logistics of pharmaceutical products, facilitating the movement of Ezetimibe from manufacturers to various markets. Their order patterns are influenced by market demand and inventory management strategies, often involving multiple shipments to different regions.

3. Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $3.39M) and VIATRIS BV C/O LIVLINA (Belgium, $2.76M) operate as intermediaries, importing Ezetimibe for the purpose of re-exporting to other countries. Their buying behavior is driven by global market demands and trade agreements, leading to variable order sizes and frequencies.

Understanding these segments is crucial for tailoring marketing strategies and supply chain operations to meet the specific needs and behaviors of each buyer type.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Ezetimibe buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Ezetimibe from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Ezetimibe complies with FDA regulations, including facility registration, product listing, and adherence to Current Good Manufacturing Practices (CGMP).

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Germany:

Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

Demand Drivers & Market Opportunity

TransData Nexus Ezetimibe buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ezetimibe in importing countries is influenced by several factors:

1. Prevalence of Hypercholesterolemia: Ezetimibe is prescribed to lower cholesterol levels, a common condition globally. The increasing prevalence of hypercholesterolemia, partly due to lifestyle changes, drives the demand for cholesterol-lowering medications.

2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding UHC schemes, increasing access to essential medicines. For instance, the inclusion of Ezetimibe in national formularies and reimbursement lists enhances its accessibility and affordability, thereby boosting demand.

3. WHO Essential Medicines List (EML) Procurement: While Ezetimibe is not currently listed on the WHO EML, its inclusion in national essential medicines lists can influence procurement decisions, especially in low- and middle-income countries aiming to improve access to essential treatments.

4. Tender-Based Purchasing: Public sector procurement often utilizes tendering processes to acquire medicines cost-effectively. Competitive tendering can lead to increased demand for Ezetimibe, as suppliers strive to meet the requirements of large-scale public health programs.

With 466 buyers across 85 countries, the global market for Ezetimibe presents significant opportunities. Understanding the interplay between disease prevalence, healthcare policies, and procurement mechanisms is vital for stakeholders aiming to optimize their market strategies.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Ezetimibe Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest ezetimibe buyer importing from India?

Based on import volume and value, DAIICHI SANKYO EUROPE GMBH (GERMANY) leads with $200.3M in imports and a 38.9% market share — the highest of any single ezetimibe importer. PCI PHARMA SERVICES (UNITED STATES) and ASCEND LABORATORIES LLC (UNITED STATES) are the next largest buyers.

QHow many companies buy ezetimibe from India?

There are 466 active ezetimibe buyers importing from India, with a combined market of $514.5M across 5,033 shipments to 85 countries. The top 5 buyers hold 84.1% of total import value, while the remaining 461 buyers handle the other 15.9%.

QWhich countries import the most ezetimibe from India?

The top importing countries for ezetimibe from India are United States (44.9%), Germany (41.4%), Netherlands (4.0%), Australia (1.3%), Belgium (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of ezetimibe, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for ezetimibe from India?

The average import transaction value for ezetimibe from India is $102.2K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Ezetimibe buyer market intelligence

1Buyer Segment Analysis

Ezetimibe imports from India are primarily distributed among the following buyer segments:

Understanding these segments is crucial for tailoring marketing strategies and supply chain operations to meet the specific needs and behaviors of each buyer type.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Ezetimibe buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Ezetimibe from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Germany:

Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

Demand Drivers & Market Opportunity

TransData Nexus Ezetimibe buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ezetimibe in importing countries is influenced by several factors:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ezetimibe

Ezetimibe

Who Buys Ezetimibe from India — 466 Importers Behind a $514.5M Market

Top Ezetimibe Importers — Ranked by Import Value

Top Ezetimibe Buyers & Importers

Related Analysis

Need Details?

Ezetimibe — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Ezetimibe — and from which countries?

Ezetimibe — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Ezetimibe Buyers & Importers

QWho is the largest ezetimibe buyer importing from India?

QHow many companies buy ezetimibe from India?

QWhich countries import the most ezetimibe from India?

QWhat is the average import order value for ezetimibe from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Germany

3Netherlands

4Australia

5Belgium

Analysis Methodology